Jeff Golini, executive scientist and developer of Kre-AlkalynTM and Kre-CelazineTM, started using FT-NIR in the early 1990’s for testing the quality of incoming raw materials in the dietary supplement industry. Today, All American Pharmaceutical’s state-of-the-art 110,000 sq. ft. contract manufacturing facility relies on FT-NIR to confirm the identity and quality of incoming ingredients as well as to assure the finished product quality both qualitatively and quantitatively.
Their in-house laboratory oversees the inbound testing of every barrel of incoming raw material and performs full testing of products from start to finish. All American Pharmaceutical’s facility is cGMP compliant and is an INFORMED CHOICE certified manufacturer. In this video, Jeff Golini tells of his experience with the Bruker Matrix I.